Biliary Proliferative Lesions in the Sprague-Dawley Rat:Adverse/Non-adverse

Toxicologic Pathology

Volumn 42, Issue 5, 2014, Pages 844-854

  Hailey, James R ^a   Nold, James B ^b   Brown, Roger H ^a   Cullen, John M ^c   Holder, Julie C ^d   Jordan, Holly L ^a   Ennulat, Daniela ^a   Miller, Richard T ^a  

^a GLAXOSMITHKLINE   (United States)

^b WIL Biotechnics LLC   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

adverse; bile duct; biliary; hyperplasia; oval cell; proliferative; rat

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; BILE DUCT; BILE DUCT TUMOR; CELL PROLIFERATION; CYTOLOGY; FEMALE; HYPERPLASIA; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; ARTICLE; BILIARY PROLIFERATIVE LESION; BILIARY TRACT DISEASE; CELL HYPERPLASIA; CHOLESTASIS; EPITHELIUM HYPERPLASIA; HEALTH HAZARD; HEPATOBILIARY DISEASE; HUMAN; LIVER CELL DAMAGE; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SPECIES DIFFERENCE;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS; BIOMARKERS; CELL PROLIFERATION; FEMALE; HYPERPLASIA; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84903614799     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313499976     Document Type: Article

References (66)

1. Alvaro D. Mancino M. G. Glaser S. Gaudio E. Marzioni M. Francis H. L. Alpini G. (2007). Proliferating cholangiocytes: A neuroendocrine compartment in the diseased liver. Gastroenterology 132, 415–31.
2. Anthony P. P. (2002). Tumors: Aetiology, epidemiology and pathology. In Pathology of the Liver (MacSween R. N. M. Burt A. D. Portmann B. C. Ishak K. G. Scheuer P. J. Anthony P. P., eds.), 4th ed., pp. 711–75. Harcourt Publishers Limited, Churchill Livingstone, Edinburgh, UK.
3. Bannasch P. (1984). Sequential cellular changes during chemical carcinogenesis. J Cancer Res Clin Oncol 108, 11–22.
4. Bannasch P. Benner U. Zerban H. (1985). Cholangiofibroma and cholangiocarcinoma, liver, rat. In Monographs on Pathology of Laboratory Animals Sponsored by the International Life Sciences Institute: Digestive System (Jones T. C. Mohr U. Hunt R. D., eds.), pp. 52–65. Springer-Verlag, Berlin, Heidelberg, Germany.
5. Bjornsson E. S. Jonasson J. G. (2013). Drug-induced cholestasis. Clin Liver Dis 17, 191–209.
6. Chun-Nan Y. Anirban M. Kam-Fai L. Yi-Yin J. Miin-Fu C. (2004). Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: An animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis 25, 631–36.
7. Craig A. Sidaway J. Holmes E. Orton T. Jackson D. Rowlinson R. Nickson J. Tonge R. Wilson I. Nicholson J. (2006). Systems toxicology: Integrated genomic, proteomic and metabonomic analysis of Methapyrilene induced hepatotoxicity in the rat. J Proteome Res 5, 1586–601.
8. de Groen P. C. Gores G. J. LaRusso N. F. Gunderson L. L. Nagorney D. M. (1999). Biliary tract cancers. New Engl J Med 341, 1368–78.
9. Dunsford H. A. Maset R. Salman J. Sell S. (1984). Connection of ductlike structures induced by a chemical hepatocarcinogen to portal bile ducts in the rat liver detected by injection of bile ducts with a pigmented barium gelatin medium. Am J Pathol 118, 218–24.
10. Elmore L. W. Sirica A. E. (1992). Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats. Hepatology 16, 1220–26.
11. Elmore L. W. Sirica A. E. (1993). “Intestinal-type” of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan. Cancer Res 53, 254–59.
12. Ennulat D. Magid-Slav M. Rehm S. Tatsuoka K. S. (2010). Diagnostic performance of traditional hepatobiliary markers of drug-induced liver injury in the rat. Toxicol Sci 116, 397–412.
13. Eustis S. L. Boorman G. A. Harada T. Popp J. A. (1990). Liver. In Pathology of the Fischer Rat: Reference and Atlas (Boorman G. A. Eustis S. L. Elwell M. R. Montgomery C. A. Jr. MacKenzie W. F., eds.), pp. 71–94. Academic Press, San Diego, CA.
14. Evans J. G. Appleby E. C. Lake B. G. Conning D. M. (1989). Studies on the induction of cholangiofibrosis by coumarin in the rat. Toxicology 55, 207–24.
15. Fausto N. (1990). Hepatocyte differentiation and liver progenitor cells. Curr Opin Cell Biol 2, 1036–42.
16. Gennero L. Roos M. A. Sperber K. Denysenko T. Bernabei P. Calisti G. F. Papotti M. Cappia S. Pagni R. Aimo G. Mengozzi G. Cavallo G. Reguzzi S. Pescarmona G. P. Ponzetto A. (2010). Pluripotent plasticity of stem cells and liver repopulation. Cell Biochem Funct 28, 178–89.
17. Giknis M. L. A. Clifford C. B. (2004). Compilation of spontaneous neoplastic lesions and survival in Crl:CD® (SD) rats from control groups. http://www.criver.com/files/pdfs/rms/cd/rm_rm_r_lesions_survival_crlcd_sd_rats.aspx.
18. Greaves P. (2000). Digestive system 2: Liver. In Histopathology of Preclinical Toxicity Studies: Interpretation and Relevance in Drug Safety Evaluation (Greaves P., ed.), 2nd ed., pp. 432–544. Elsevier Sciences B.B, Amsterdam, the Netherlands.
19. Greenblatt M. (1982). Tumours of the liver. In Pathology of Tumors in Laboratory Animals: Tumours of the Hamster (Turusov V.S., ed.), Vol. 3, pp. 69–101. IARC Scientific Publication, Lyon, France.
20. Haseman J. K. Arnold J. Eustis S. L. (1990). Tumor incidences in Fischer 344 rats: NTP historical data. In Pathology of the Fischer Rat: Reference and Atlas (Boorman G. A. Eustis S. L. Elwell M. R. Montgomery C. A. Jr. MacKenzie W.F., eds.), pp. 555–64. Academic Press, San Diego, CA.
21. Houle C. (2005). Evaluation of acute toxicity of thioacetamide in orally dosed male F344 rats: Histopathologic review of liver and kidney pathology (National Toxicology Program). Pathology Working Group Chairperson’s Report No. 8/2/05, NIEHS, Research Triangle Park, NC.
22. Housset C. (2000). Biliary epithelium, hepatocytes and oval cells. Rev Prat 50, 2106–211.
23. Ishak K. G. Sharp H. L. (2002). Developmental abnormalities and liver disease in childhood. In Pathology of the Liver (MacSween R. N. M. Burt A. D. Portmann B. C. Ishak K. G. Scheuer P. J. Anthony P. P., eds.), 4th ed., pp. 107–54. Harcourt Publishers Limited, Churchill Livingstone, Edinburgh, UK.
24. Jamison K. C. Larson J. L. Butterworth B. E. Harden R. Skinner B. L. Wolf D.C. (1996). A non-bile duct origin for intestinal crypt-like ducts with periductular fibrosis induced in livers of F344 rats by chloroform inhalation. Carcinogenesis 17, 675–82.
25. Kountouras J. Billing B. H. Scheuer P. J. (1984). Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. British Journal of Experimental Pathology 65, 305–11.
26. Lankisch T. O. Metzger J Ahmed A. N. Vobkuhl K. Schiffer E. Siwy J. Weismuller T. J. Schneider A. S. Thedieck K. Baumeister R. Zurbig P. Weissinger E. M. Manns M. P. Mischak H. Wedemeyer J. (2011). Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 53, 875–84.
27. Leonard T. B. Neptun D. A. Popp J. A. Leonard T. B. Neptun D. A. Popp J. A. (1984). Serum gamma glutamyl transferase is a specific indicator of bile duct lesions in the rat liver. Am J Pathol 116, 262–69.
28. LeSage G. Glaser S. Alpini G. (Munksgaard, 2001). Regulation of cholangiocyte proliferation. Liver 21, 73–80.
29. Lewis R. W. Billington R. Debryune E. Gamer A. Lang B. Carpanni F. (2002). Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol 30, 66–74.
30. Maronpot R. R. Giles H. D. Dykes D. J. Irwin R. D. (1991). Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 19, 561–70.
31. McConnell E. E. Solleveld H. A. Swenberg J. A. Boorman G. A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J Natl Cancer Inst 76, 283–89.
32. National Cancer Institute (1979). Bioassay of p-Cresidine for Possible Carcinogenicity (CAS 120-71-8). NCI report 142, NIH Publication No. 79-1397, National Institute of Health, Bethesda, MD.
33. National Toxicology Program (1983). Toxicology and Carcinogenesis Studies of a Polybrominated Biphenyl Mixture (Firemaster FF-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP TR 244, NIH Publication No. 83-1800, NIEHS, Research Triangle Park, NC.
34. National Toxicology Program (1993b). Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice (Gavage Studies). NTP TR 402, NIH Publication No. 93-2857, NIEHS, Research Triangle Park, NC.
35. National Toxicology Program (1993c). Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). NTP TR 422, NIH Publication No. 93-3153, NIEHS, Research Triangle Park, NC.
36. National Toxicology Program (1995). Toxicology and Carcinogenesis Studies of Butyl Benzyl Phthalate (CAS No. 85-68-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP TR 458, NIH Publication No. 95-3374, NIEHS, Research Triangle Park, NC.
37. National Toxicology Program (1996). Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344 Rats and B6C3F1 Mice (Feed Studies). NTP TR 383, NIH Publication No. 96-2838, NIEHS, Research Triangle Park, NC.
38. National Toxicology Program (2000). Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-2) in F344/N Rats and B6C3F1 Mice. NTP TR 491, NIH Publication No. 00-3950, NIEHS, Research Triangle Park, NC.
39. National Toxicology Program (2002). Toxicology and Carcinogenesis Studies of o-Nitrotoluene (CAS No. 88-72-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). NTP TR 504, NIH Publication No. 02-4438, NIEHS, Research Triangle Park, NC.
40. National Toxicology Program (2006a). Toxicology and Carcinogenesis Studies of 3,3′4,4′5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 520, NIH Publication No. 06-4454, NIEHS, Research Triangle Park, NC.
41. National Toxicology Program (2006b). Toxicology and Carcinogenesis Studies of a mixture of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 521, NIH Publication No. 06-4468, NIEHS, Research Triangle Park, NC.
42. National Toxicology Program (2006c). Toxicology and Carcinogenesis Studies of 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 525, NIH Publication No. 06-4461, NIEHS, Research Triangle Park, NC.
43. National Toxicology Program (2006d). Toxicology and Carcinogenesis Studies of a Mixture of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6), 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4), and 3,3′4,4′5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 526, NIH Publication No. 06-4462, NIEHS, Research Triangle Park, NC.
44. National Toxicology Program (2006e). Toxicology and Carcinogenesis Studies of 2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 529, NIH Publication No. 06-4465, NIEHS, Research Triangle Park, NC.
45. National Toxicology Program (2006f). Toxicology and Carcinogenesis Studies of a Binary Mixture of 3,3′,4,4′,5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) and 2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 530, NIH Publication No. 06-4466, NIEHS, Research Triangle Park, NC.
46. National Toxicology Program (2006g). Toxicology and Carcinogenesis Studies of a Binary Mixture of 3,3′,4,4′,5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) and 2,3′,4,4′,5-Pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 531, NIH Publication No. 07-4467, NIEHS, Research Triangle Park, NC.
47. National Toxicology Program (2010a). Toxicology and Carcinogenesis Studies of 3,3′,4,4′-Tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley Rats and B6C3F1 Mice (Gavage Studies). NTP TR 558, NIH Publication No. 11-5899, NIEHS, Research Triangle Park, NC.
48. National Toxicology Program (2010b). Toxicology and Carcinogenesis Studies of 2,3′,4,4′,5-Pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in Female Harlan Sprague-Dawley Rats (Gavage Studies). NTP TR 559, NIH Publication No. 11-5900, NIEHS, Research Triangle Park, NC.
49. Ohshima M. Ward J. M. Brennan L. M. Creasia D. A. (1984). A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats. J Natl Cancer Inst 72, 759–68.
50. Paku S. Kopper L. Nagy P. (2005). Immunohistochemical analysis of cytokeratin 7 expression in resting and proliferating biliary structures of rat liver. Hepatology 42, 863–70.
51. Praet M. M. Roels H. J. (1989). An enzyme histochemical analysis of the different steps in thioacetamide induced liver carcinogenesis in rats. Acta Histochem Suppl 37, 161–67.
52. Priester S. Wise C. Glaser S. S. (2010). Involvement of cholangiocyte proliferation in biliary fibrosis. World J Gastrointest Pathophysiol 1, 30–37.
53. Reuber M. D. (1979). Carcinogenicity of chloroform. Environ Health Perspect 31, 171–82.
54. Roskams T. A. Yang S. Q. Koteish A. Durnez A. DeVos R. Huang X. Achten R. Verslype C. Diehl A. M. (2003). Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163, 1301–11.
55. T.A., Roskams, N.D., Theise, C., Balabaud, Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers, Hepatology, (2004), 39, 1739-1745
56. Schauer A. Kunze E. (1976). Tumours of the liver. In Pathology of Tumors in Laboratory Animals Vol 1—Tumours of the Rat (Turusov V. S., ed.), pp. 41–72, IARC Publ No. 6, IARC Scientific Publication, Lyon, France
57. Seki M. Yanagisawa A. Ninomiya E. Ninomiya Y. Hhta H. Saiura A. Yamamoto J. Yamaguchi T. Aruga A. Yamada K. Takano K. Fujita R. Ikeda M. Sakaki K. Kato Y. (2005). Clinicopathology of pancreaticobiliary maljunction: Relationship between alterations in background biliary epithelium and neoplastic development. J Hepatobiliary Pancreat Surg 12, 254–62.
58. Sell S. Dunsford H. A. (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 134, 1347–63.
59. Sirica A. E. (1995). Ductular hepatocytes. Histol Histopathol 10, 433–56.
60. Sonzogni A. Colloredo G. Fabris L. Cadamuro M. Paris G. Roffi L. Pozzi M. Bovo G. Del Poggio P. Portmann B. C. Strazzabosco M. (2004). Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests. J Hepatol 40, 592–98.
61. Stewart H. L. Williams G. Keysser C. H. Lombard L. S. Montali R. J. (1980). Histologic typing of liver tumors of the rat. J Natl Cancer Inst 64, 178–206.
62. Svegliati-Baroni G. De Minicis S. Marzioni M. (2008). Hepatic fibrogenesis in response to chronic liver injury: Novel insights on the role of cell-to-cell interation and transition. Liver Int 28, 1052–64.
63. Tatematsu M. Ho R. H. Kaku T. Ekem J. K. Farber E. (1984). Studies on the proliferation and fate of oval cells in the liver of rats treated with 2-acetylaminofluorene and partial hepatectomy. Am J Pathol 114, 418–30.
64. Thoolen B. Maronpot R. R. Harada T. Nyska A. Rousseaux C. Nolte T. Malarkey D. E. Kaufmann W. Küttler K. Deschl U. Nakae D. Gregson R. Vinlove M. P. Brix A. E. Singh B. Belpoggi F. Ward J. M. (2010). Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38, 5S–81S.
65. Zimmerman H. J. (1999a). Hepatotoxicity—Vulnerability of the Liver to Toxic Injury: The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA, 41–60.
66. Zimmerman H. J. (1999b). Hepatotoxicity—Toxic Cholestasis: The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA, 295–323.